Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A
L J Kay, Tora K Smulders-Srinivasan, M. Soundararajan
Advances in protein chemistry and structural biology (2016), pp. 127-171
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome
Eva Lana‐Elola, Rifdat Aoidi, Miriam Llorian, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 18
Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease
Daniel J. Colacurcio, Anna Pensalfini, Ying Jiang, et al.
Free Radical Biology and Medicine (2017) Vol. 114, pp. 40-51
Open Access | Times Cited: 148
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg, Laurent Meijer
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6047-6047
Open Access | Times Cited: 81
Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome
Anouchka P. Laurent, Rishi S. Kotecha, Sébastien Malinge
Leukemia (2020) Vol. 34, Iss. 8, pp. 1984-1999
Open Access | Times Cited: 66
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature
Thu Lan Nguyen, Corinne Fruit, Yann Hérault, et al.
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 11, pp. 1183-1199
Closed Access | Times Cited: 55
Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade
Ching‐Chi Chiu, Tu-Hsueh Yeh, Rou-Shayn Chen, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 45
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Mariko Sawa, Cassia Overk, Ann Becker, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 6, pp. 1203-1234
Open Access | Times Cited: 38
Zebrafish as an emerging model to study gonad development
Mengling Ye, Ye Chen
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 2373-2380
Open Access | Times Cited: 33
How a gene fuels ear infections
Sedigheh Delmaghani, A. Amraoui
eLife (2025) Vol. 14
Open Access
DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers
Shanshan Li, Xu Chu, Yinkun Fu, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 21, pp. 11202-11213
Open Access | Times Cited: 37
Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms
Anne T. Berg, Samya Chakravorty, Sookyong Koh, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0193599-e0193599
Open Access | Times Cited: 30
Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review
Marta Pilar Osuna‐Marco, M López-Barahona, Blanca López‐Ibor, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 23
Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects
Yasmeen T. AlNajjar, Moustafa T. Gabr, Ahmed K. ElHady, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113911-113911
Closed Access | Times Cited: 20
K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR
Pengshan Zhang, Zhe Zhang, Yinkun Fu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 19
Structure–Activity Relationship in the Leucettine Family of Kinase Inhibitors
Tania Tahtouh, Émilie Durieu, Benoît Villiers, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 1396-1417
Closed Access | Times Cited: 19
DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease
Márcia María de Souza, Arthur Ribeiro Cenci, Kerolain Faoro Teixeira, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 6, pp. 669-688
Closed Access | Times Cited: 13
Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues
Jacqueline London, Claude Rouch, Linh Chi Bui, et al.
Molecular Neurobiology (2017)
Closed Access | Times Cited: 23
DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes
Bangfu Zhu, Tom Parsons, Wenche Stensen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
Bangfu Zhu, Tom Parsons, Christopher Foley, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Insights from the protein interaction Universe of the multifunctional “Goldilocks” kinase DYRK1A
Varsha Ananthapadmanabhan, Kathryn H. Shows, Amanda Dickinson, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
Mina Yousefelahiyeh, Jingyi Xu, Estibaliz Alvarado, et al.
PLoS ONE (2018) Vol. 13, Iss. 11, pp. e0207779-e0207779
Open Access | Times Cited: 15
DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature
Laura E. Meissner, Ellen F. Macnamara, Precilla D’Souza, et al.
Molecular Genetics & Genomic Medicine (2020) Vol. 8, Iss. 12
Open Access | Times Cited: 14
Triple play of DYRK1A kinase in cortical progenitor cells of Trisomy 21
Nobuhiro Kurabayashi, Minh Dang Nguyen, Kamon Sanada
Neuroscience Research (2018) Vol. 138, pp. 19-25
Closed Access | Times Cited: 13
Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors
Gianmarco Pallavicini, Gaia Berto, Ferdinando Di Cunto
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2098-2098
Open Access | Times Cited: 13
Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila
Simon A. Lowe, Maria M. Usowicz, James J. L. Hodge
Neurobiology of Disease (2019) Vol. 125, pp. 107-114
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top